Rapaprutug

拉帕扑塔单抗

Report date: 2025/11/11 17:42:57

Base Information

Drug NameRapaprutug
Drug Alias NameZMA001ZMA-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLysine-tRNA ligase inhibitors
TargetsLysine-tRNA ligase
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Heart, Lung And Blood InstituteZymedi Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZymedi Co LtdNational Heart, Lung And Blood InstituteNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A